Home Markets Regeneron slides as Amgen wins Eylea biosimilar case; RBC still bullish

Regeneron slides as Amgen wins Eylea biosimilar case; RBC still bullish

Sep 24, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/regeneron-slides-as-amgen-wins-eylea-biosimilar-case-rbc-still-bullish-3628943

You May Also Like

Brazil’s Vale drops IPO plans for critical minerals unit, The Globe and Mail reports

Tesla says it is offering Cybercab rides in limited areas of Austin, Texas

Volkswagen announces major restructuring: how will its suppliers be affected?

U.S. stock futures flat amid Iran, rate caution; Broadcom dips after earnings

New Jersey takes fight over Kalshi’s prediction market to US Supreme Court

From hunger to obesity: Developing world faces growing threat to child health